SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathwayYing Wang(Central South University), Jing Wang(Central South University)Medical OncologyJanuary 10, 202310.1007/s12032-022-01944-0Cited by 32SaveCiteExport RISWatch citationsRelated PapersPARP inhibitor resistance: the underlying mechanisms and clinical implications|Molecular Cancer|2020|527